2004

“EVENTS” 3D text surrounded by calendar dates. Part of a series.

 

  • September 2004 – Early Detection Research Network, Lung Cancer Biomarker Workshop, September 18-20, 2004, University of Colorado, Denver, CO, “Validation Study on a Biomarker Panel for Early Lung Cancer Detection in Serum” Invited Speaker, Dr. Moncef Jendoubi. In Collaboration with the NCI (EDRN) Milagen has conducted a blind experiment and has successfully validated its immunodiagnostic biomarkers for the early detection of lung cancer in serum
  • September 2004 – Early Detection Research Network, GU Collaborative Group Meeting, September 13-14, 2004, Houston TX, Invited Speaker, Dr. Moncef Jendoubi
  • July 2004 – AACC Annual Meeting, American Association of Clinical Chemistry, July 25-29, 2004, Los Angeles, CA, Dr. Moncef Jendoubi
  • July 2004 – Milagen is awarded two-year grant funding through Associate Membership with the Early Detection Research Network for “ Antibody early detection of prostate cancer biomarkers”
  • June 2004 – 40th Annual ASCO Meeting, American Association of Clinical Oncology, June 5-8, 2004, New Orleans, LO, “Candidate Secreted Biomarkers for Prostate Cancer Detection” C. Chavany, S. Chen, S. Schramm, R.P.C. Valle, J.O. Semmes*, M. Jendoubi, * Eastern Virginia Medical School, Poster Presentation, Dr. Moncef Jendoubi
  • June 2004 – Early Detection Research Network, EDRN Associate Member Meeting, June 12-14, 2004, Bethesda, MD, “Antibody-Based Early Detection of Prostate Cancer Biomarkers” C. Chavany, S. Chen, S. Schramm, R.P.C. Valle, G. Malik*, J.O. Semmes*, M. Jendoubi, * Eastern Virginia Medical School, Roundtable Discussion Panelist, Dr. Moncef Jendoubi
  • May 15, 2004 – Milagen exceeds set milestones in the Final Report of NCI Phase I Small Business Innovation Research Contract (SBIR) on “High-Throughput Protein Profiling in Mouse Models of Cancer”
  • March 2004 – 95th Annual Meeting, American Association for Cancer Research, March 27-31, 2004, Orlando, FL, “Candidate Secreted Biomarkers for the Early Detection of Lung Cancer” C. Chavany, S. Schramm, R.P.C. Valle, M. Jendoubi, A. Greenberg*, W.N. Rom*, *NYU School of Medicine, Poster Presentation, Dr. Christine Chavany
  • March 2004 – 60th Annual Meeting, American Academy of Allergy, Asthma, & Immunology, March 19-23, 2004, San Francisco, CA, “Candidate Serum Biomarkers for Predictive Medicine and Disease Management of Asthma” J. Just*, C. Chavany, K. Yamaguchi, S. Chen, S. Schramm, F. Sahraoui*, A. Grimfeld*, M. Jendoubi, * Hospital Armand Trousseau, Paris, France, Poster Presentation, Dr. Christine Chavany
  • March 2004 – Fred Hutchinson Cancer Research Center, March 18, 2004, Seattle, WA, “Discovery and Validation of Biomarkers and their Utility Application for Diagnostic and Disease Management in Cancer” Invited Speaker, Dr. Moncef Jendoubi
  • February 2004 – Scientific and Technological Advances in Cancer Research, IBC LifeSciences, February 11-13, 2004, Reston, VA, “ Discovery and Validation of Molecular Signatures and their Utility Application for Diagnostic and Disease Management in Cancer” Invited Speaker, Dr. Moncef Jendoubi
  • February 6, 2004 – Milagen is awarded Associate Membership with the Early Detection Research Network
  • February 2004 – 9th EDRN Steering Committee Meeting, Early Detection Research Network, February 2-4, 2004, University of Texas Southwestern Medical Center, Dallas, TX, “Antibody Array for Cancer Detection” Guest Speaker, Dr. Moncef Jendoubi